Since its first description in 2009, Candida auris has, so far, resulted in large hospital
outbreaks worldwide and is considered an emerging global public health threat …

The frequency of co-infections with bacterial or fungal pathogens has constantly increased
among critically ill patients with coronavirus disease 2019 (COVID-19) during the pandemic …

Background New and emerging infectious diseases continue to represent a public health
threat. Emerging infectious disease threats include pathogens increasing in range (eg …

Introduction Excessive use of antibiotics has been frequently reported in hospitalized
patients with COVID-19 worldwide, compared to the actual number of bacterial co-infections …

Opportunistic fungi cause lethal systemic infections and impose high medical costs to health
systems. The World Health Organization has recognized the importance of fungal infections …

Invasive fungal infections increase mortality and morbidity rates worldwide. The treatment of
these infections is still limited due to the low bioavailability and toxicity, requiring therapeutic …

Introduction Candida auris is included in the fungal infection category 'critical'by WHO
because of associated high drug tolerance and spread at an alarming rate which if remains …

Candida auris poses a serious threat to infection control and patient care since it can
produce invasive infections that have a high fatality rate, has been linked to outbreaks in …

Candida auris is a multidrug-resistant fungal pathogen with a propensity to colonize humans
and persist on environmental surfaces. C. auris invasive fungal disease is being …

Background: Candida auris is an emerging multidrug-resistant fungal pathogen that
represents a current serious threat to healthcare settings. Objective: The objective was to …